Skip to main content

Symposium 2014: Finding Vulnerabilities in Cells Dependent on Mutant KRAS

Symposium 2014: Finding Vulnerabilities in Cells Dependent on Mutant KRAS

Dr. Julian Downward, the Cancer Research UK London Institute, describes interactions between PI3K and KRAS, synthetic lethal screens, and circulating tumor DNA.